BSEBoard Meeting22 Oct 2026 · 22 Oct 2026, 06:17 pm

Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended 30th September 2026.

Sanofi Consumer Healthcare India Ltd · 544250

✦ AI SummaryResults

Sanofi Consumer Healthcare India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 28/10/2026 to consider and approve the Unaudited Financial Results for the quarter and nine months ended 30th September 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sanofi Consumer Healthcare India Ltd - 544250 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2026.

Attachments (1)

📄

0dbc21c0-6fd4-4cfc-8e26-e246cdecfc6a.pdf

pdf

Download →
View document text
22nd October 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, C-1, Block G, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Mumbai - 400 001 Bandra East, Mumbai - 400 051 Scrip Code: 544250 Symbol: SANOFICONR Sub.: Intimation of Board Meeting to be held on 28th October 2026 under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Wednesday, 28th October 2026, inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 30th September 2026. Further, in reference to our letter dated 28th September 2026, we would also like to inform you that as per the “Sanofi Consumer Healthcare India Limited – Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons”, the trading window for the purpose of publication of Unaudited Financial Results of the Company for the quarter and nine months ended 30th September 2026, shall remain closed from Thursday, 1st October 2026 to Friday, 30th October 2026 (both days inclusive). Kindly take the above information on record. Thanking you. Yours faithfully, For Sanofi Consumer Healthcare India Limited Nikunjkumar Savaliya Company Secretary and Compliance Officer Membership No.: F7048 Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079 Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com